NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1992

被引：41

作者：

DIMASI, JA

SEIBRING, MA

LASAGNA, L

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1994年 / 55卷 / 06期

关键词：

D O I：

10.1038/clpt.1994.78

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：609 / 622

页数：14

相关论文

共 21 条

[1] BIOPHARMACEUTICALS AND CONVENTIONAL DRUGS - CLINICAL SUCCESS RATES
BIENZTADMOR, B
DICERBO, PA
TADMOR, G
LASAGNA, L
[J]. BIO-TECHNOLOGY, 1992, 10 (05): : 521 - 525
[2] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY
DIMASI, JA
HANSEN, RW
GRABOWSKI, HG
LASAGNA, L
[J]. JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) : 107 - 142
[3] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1990
DIMASI, JA
BRYANT, NR
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) : 471 - 486
[4] KAITIN KI, 1992, DRUG INF J, V26, P341
[5] NEW DRUG DEVELOPMENT IN THE UNITED-STATES, 1963 THROUGH 1984
MATTISON, N
TRIMBLE, AG
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (03) : 290 - 301
[6] NEW DRUG DEVELOPMENT DURING AND AFTER A PERIOD OF REGULATORY CHANGE - CLINICAL RESEARCH ACTIVITY OF MAJOR UNITED-STATES PHARMACEUTICAL FIRMS, 1958 TO 1979
MAY, MS
WARDELL, WM
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) : 691 - 700
[7] TEMPLE R, 1993, DRUG INF J, V27, P355
[8] DEVELOPMENT OF NEW DRUGS ORIGINATED AND ACQUIRED BY UNITED-STATES-OWNED PHARMACEUTICAL FIRMS, 1963-1976
WARDELL, WM
DIRADDO, J
TRIMBLE, AG
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 270 - 277
[9] WARDELL WM, 1978, CLIN PHARMACOL THER, V24, P133
[10] NEW DRUG DEVELOPMENT BY UNITED-STATES PHARMACEUTICAL FIRMS WITH ANALYSES OF TRENDS IN THE ACQUISITION AND ORIGIN OF DRUG CANDIDATES, 1963-1979
WARDELL, WM
MAY, MS
TRIMBLE, AG
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (04) : 407 - 417